Amneal reports certain preliminary third quarter 2023 financial results and raises full year 2023 financial guidance

Bridgewater, n.j.--(business wire)--amneal pharmaceuticals, inc. (nyse: amrx) (“amneal” or the “company”) today announced certain unaudited preliminary financial results for the third quarter ended september 30, 2023. the company also raised its financial guidance for the year ending december 31, 2023, which was most recently issued on august 4, 2023. the company plans to report actual third quarter 2023 financial results on november 7, 2023. unaudited preliminary financial results for the thir.
AMRX Ratings Summary
AMRX Quant Ranking